Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity

Schlondorff, 1986, Platelet-activating factor and kidney, Am J Physiol, 251, F1 Vemulapalli, 1984, Cardiovascular and renal action of platelet-activating factor in anesthetized dogs, Hypertension, 6, 489, 10.1161/01.HYP.6.4.489 Pirotzky, 1984, Release of platelet activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys, Kidney Int, 25, 404, 10.1038/ki.1984.31 Badr, 1989, Glomerular responses to platelet activating factor in the rat: Role of thromboxane A2, Am J Physiol, 256, F35 Scholondorff, 1984, Effect of platelet activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release and contraction of cultured rat mesangial cells, J Clin Invest, 73, 1227, 10.1172/JCI111309 Santos, 1989, Effect of platelet activating factor antagonist on cyclosporin nephrotoxicity: Glomerular hemodynamics evaluation, Transplant, 47, 592, 10.1097/00007890-198904000-00005 Einhorn, 1979, Current concepts in cancer: The role of cisplatinum in solid tumor therapy, N Engl J Med, 300, 289, 10.1056/NEJM197902083000605 Ries, 1986, Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity, Am J Kid Dis, 8, 368, 10.1016/S0272-6386(86)80112-3 Winston, 1985, Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat, Am J Physiol, 249, F490 Baylis, 1977, Mechanisms of the defects in glomerular ultrafiltration associated with gentamicin administration, Kidney Int, 12, 344, 10.1038/ki.1977.121 Schor, 1981, Pathophysiology of altered glomerular function in aminoglycoside-treated rats, Kidney Int, 19, 288, 10.1038/ki.1981.19 Maddox, 1977, Effects of surgery on plasma volume and salt and water excretion in rats, Am J Physiol, 233, F600 Deen, 1972, A model of glomerular ultrafiltration in the rat, Am J Physiol, 223, 1178, 10.1152/ajplegacy.1972.223.5.1178 Deen, 1973, Dynamics of glomerular ultrafiltration in the rat: IV Determination of ultrafiltration coefficient, JClin Invest, 52, 1500, 10.1172/JCI107324 Fuhr, 1955, Eine einfache colorime-trishe Methode zur Inulin Bestimmung fur Nierenclearanceunter-suchungen bei Soff wechselgesumden und Diabetikern, Klin Wochenschr, 33, 729, 10.1007/BF01473295 Smith, 1945, The renal clearances of substituted hippuric acid derivates and other aromatic acids in dog and man, J Clin Invest, 24, 388, 10.1172/JCI101618 Vurek, 1978, Fluorimetric method for the determination of nanogram quantities of inulin, Anal Biochem, 88, 513 Viets, 1978, Determination of serum protein concentration in nanoliter blood samples using fluorescamine or o-phthalaldehyde, Anal Biochem, 88, 513, 10.1016/0003-2697(78)90451-7 Pirotzky, 1984, Biosynthesis of platelet activating factor VI. Precursor of platelet activating factor and acetyltransferase activity in isolated rat kidney cells, Lab Invest, 51, 567 Robertson, 1972, Dynamics of glomeular ultrafiltrationo in the rat. Ill Hemodynamics and auto-regulation, Am J Physiol, 223, 1191, 10.1152/ajplegacy.1972.223.5.1191 Egido, 1988, Papel de los antagonistas del factor activador de las plaquetas (PAF) en la nefrotoxicidad induzida por la ciclosporina en ratos, Nefrologia, VIII, 30 Barros, 1987, Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity, Kidney Int, 32, 19, 10.1038/ki.1987.166 Braquet, 1985, BN52021 and related compounds: New series of highly specific PAF-acether receptor antagonists isolated from, Gingko biloba. Blood Ves, 16, 558, 10.2491/jjsth1970.16.558 Braquet, 1987, The gingkolides: Potent platelet activating factor antagonists isolated from Gingko biloba I: Chemistry, pharmachol-ogy and clinical application, Drugs of the Future, 12, 643, 10.1358/dof.1987.012.07.77903 Sauders, 1987, Platelet activating factor antagonists, Ann Rev Pharmachol Toxicol, 27, 237, 10.1146/annurev.pa.27.040187.001321 Schor, 1981, Mechanism of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat, Kidney Int, 20, 442, 10.1038/ki.1981.160 Wittes, 1977, Cisdichlorodiammine platinum (II) in the treatment of epidermoid carcinoma of the head and neck, Cancer Treat, 61, 359 Jones, 1985, Cisdiamminedichloroplatinum, (Il)-induced acute renal failure in the rat. Correlation of structural and functional alterations, Lab Invest, 52, 363 Clifton, 1982, Early polyuria in the rat following single dose cis-dichlorodiammine platinum, J Lab Clin Med, 100, 659 Safirstein, 1981, Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity, Am J Physiol, 241, F175 Safirstein, 1986, Cisplatin nephrotoxicity, Am J Kid Dis, 8, 356, 10.1016/S0272-6386(86)80111-1 Chopra, 1982, Cis-diam-mininedichloroplatinum-induced acute renal failure in the rat, Kidney Int, 21, 54, 10.1038/ki.1982.8 Safirstein, 1981, Cisplatin nephrotoxicity in rats, 91 Pirotzky, 1989, Effect of PAF-antagonists in various models of nephrotoxicity in the rat, 29 Caparro, 1987, Atrial natriuretic factor increases glomerular filtration rate in the experimental acute renal failure induced by cisplatin, Adv Exp Med Biol, 212, 285, 10.1007/978-1-4684-8240-9_35 McGuiness, 1978, Amelioration of cis-platinum nephrotoxicity by orgotein (superoxido dismutase), Physiol Che m Phys, 10, 367 Hou, 1983, Hospital-acquired renal insufficiency: A prospective study, Am J Med, 74, 248, 10.1016/0002-9343(83)90618-6 Senekjian, 1981, Micropuncture study of the handling of gentamicin by the rat kidney, Kidney Int, 19, 416, 10.1038/ki.1981.34 Luft, 1979, Salt-susceptible hypertension following gentamicin-induced glomerular injury, Clin Res, 27, 674A Neuwirth, 1989, Angiotensin II causes formation of platelet activating factor in cultured rat mesangial cells, Circ Res, 64, 1224, 10.1161/01.RES.64.6.1224